Atomi Financial Group’s Gilead Sciences GILD Stock Holding History

Atomi Financial Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.45M	Buy	39,125 +2,977	+8%	+$417K	0.17%	113
2025 Q4	$4.44M	Sell	36,148 -2,847	-7%	-$346K	0.13%	124
2025 Q3	$4.33M	Buy	38,995 +2,799	+8%	+$318K	0.14%	118
2025 Q2	$4.01M	Buy	36,196 +13,003	+56%	+$1.38M	0.15%	105
2025 Q1	$2.6M	Buy	23,193 +14,881	+179%	+$1.54M	0.12%	135
2024 Q4	$768K	Buy	8,312 +2,231	+37%	+$201K	0.04%	333
2024 Q3	$510K	Buy	6,081 +1,610	+36%	+$123K	0.03%	443
2024 Q2	$307K	Sell	4,471 -809	-15%	-$54K	0.02%	579
2024 Q1	$387K	Sell	5,280 -498	-9%	-$38.3K	0.04%	434
2023 Q4	$468K	Buy	+5,778	New	+$450K	0.06%	288

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Atomi Financial Group's GILD Position: Q1 2026 in Review

Atomi Financial Group increased its Gilead Sciences (GILD) stake by 8.2% in Q1 2026, buying an estimated $417K and bringing the position to 39,125 shares worth $5.45M. The position accounts for 0.17% of the portfolio, ranked #113.

Atomi Financial Group first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Atomi Financial Group held 39,125 shares of Gilead Sciences worth $5.45M as of Q1 2026.
Atomi Financial Group bought 2,977 Gilead Sciences shares in Q1 2026, an estimated $417K.
Gilead Sciences made up 0.17% of Atomi Financial Group's portfolio in Q1 2026, its #113 holding.
Atomi Financial Group first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Atomi Financial Group's 13F filing for Q1 2026, filed 14 May 2026.